Chlorhexidine Gluconate 20% 0012 Medichem
Discoloration.
708 recalls · Class II, newest first
Discoloration.
CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.
CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.
CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Defective Delivery System: Sustained trend of failure to dispense complaints.
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.
Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.
CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.
CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.
CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.
Failed Stability Specifications: Below specification result for buprenorphine release rate.
CGMP Deviations
CGMP Deviations: Product manufactured in a facility where methanol was found in other distributed lots of product.
Marketed without an Approved NDA/ANDA.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.
CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.